Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of rosuvastatin 20 mg film-coated tablets in healthy Thai volunteers
TCTR20180725005Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin (2 arms), sponsored by International Bio Service. Primary endpoints: Cmax, AUC0-tlast and 1 more. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
rosuvastatin
Beyond the preview
Go deeper on TCTR20180725005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180725005.